The study will examine vaccine safety, efficacy and immunity at lower doses. Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical ...

London-based Exco InTouch, which is providing Pfizer with the mobile clinical trial technology its using in its REMOTE study, has secured about $4.67 million from Scottish Equity Partners (SEP). Exco ...

Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The ...

NEW HAVEN, Conn. and NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial ...

Tuesday Pfizer announced it's expanding its clinical trials for younger children ages 5 to 11-years-old. Medical doctors are calling this the final frontier. This is a 2-year study, where a subset of ...

US pharma giant Pfizer on Saturday announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...

Pfizer has officially ended its development of the experimental weight-loss pill, danuglipron, after a potential drug-induced liver injury was reported during a clinical trial. This decision comes as ...

Earnings Call Insights: Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2024 Co-CEO Bob Duggan emphasized recent milestones, ...

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (OLMA) (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, ...